Basic Pharma Life Science Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 06-07-2024
- Paid Up Capital ₹ 3.48 M
as on 06-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.03 Cr
as on 06-07-2024
- Satisfied Charges ₹ 3.47 Cr
as on 06-07-2024
- Revenue -46.97%
(FY 2022)
- Profit -95.56%
(FY 2022)
- Ebitda -97.89%
(FY 2022)
- Net Worth 2.54%
(FY 2022)
- Total Assets 4.64%
(FY 2022)
About Basic Pharma Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.48 M.
The company currently has active open charges totaling ₹10.03 Cr. The company has closed loans amounting to ₹3.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paresh Vaghasia, Nileshkumar Gondaliya, Mukesh Thummar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046278
- Company No.
046278
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Basic Pharma Life Science?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Vaghasia  | Director | 20-Jun-2005 | Current |
| Nileshkumar Gondaliya | Director | 20-Jun-2005 | Current |
| Mukesh Thummar | Director | 20-Jun-2005 | Current |
| Maheshbhai Vekaria | Director | 20-Jun-2005 | Current |
Financial Performance of Basic Pharma Life Science.
Basic Pharma Life Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.97% decrease. The company also saw a substantial fall in profitability, with a 95.56% decrease in profit. The company's net worth moved up by a moderate rise of 2.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Basic Pharma Life Science?
In 2022, Basic Pharma Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ankleshwar Waste Management AssociationActive 7 years 8 monthsNileshkumar Gondaliya is a mutual person
Takshshila Vidhyapith Private LimitedActive 13 years 10 monthsParesh Vaghasia, Nileshkumar Gondaliya and 2 more are mutual person
- Plasma Energy Applied Technologies Ankleshwar Private LimitedActive 16 years 2 months
Paresh Vaghasia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Feb 2022 | ₹0.60 M | Open |
Axis Bank Limited Creation Date: 08 Jul 2011 | ₹9.97 Cr | Open |
Bankof Baroda Creation Date: 14 Jul 2006 | ₹1.16 Cr | Satisfied |
How Many Employees Work at Basic Pharma Life Science?
Basic Pharma Life Science has a workforce of 53 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Basic Pharma Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basic Pharma Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
